You've hidden all cards
Retirees Who File SSA-44 in October With an Income Estimate Can Get 2027 IRMAA Fixed Before January. Wait for the Notice and the Refund Chase May Come Instead
Medicare prices your 2027 Part B premium from income you earned two years ago, and Social Security has no reason to look again unless you force it. One form filed in October changes that math before the first January check arrives.
After-hours
$171.09
+7.60%open $159.00
A 7.6% run to $171.09 on a $1.3 trillion company is roughly $99 billion of value in a single session, a size of move most megacaps never see. Watch whether the after-hours bid holds into tomorrow's open.
Gainers
Losers
Both Petrobras lines closed double digits higher, the only names in a 383-stock board to do it. MercadoLibre and Tempus AI each added more than 9%, while the worst loser gave up under 5%, so the upside skew was lopsided.
You Inherited $260,000 at 66 and It Is Sitting in Cash? Every Month It Sits Is a Month It Does Not Work. These 3 ETFs Put It to Work Without Starting Over
A $260,000 inheritance sitting in a bank account after a loss feels like caution, but the math tells a different story about what that patience is actually costing. Three funds change the equation without forcing you to rebuild what you already have.
CLOSING BELL
U.S. Markets
- S&P 500+0.84%
- Dow Jones Industrial Average+0.36%
- Nasdaq Composite+1.06%
Tech did the heavy lifting again: the Nasdaq's 1.06% gain nearly tripled the Dow's 0.36%, leaving the S&P 500 at 7,787.91. Anyone underweight growth names fell further behind today.
Regular session
$406.18
+4.20%open $389.80
A 4.2% intraday run to $406.18 adds roughly $6 billion to a $145 billion medtech name that rarely moves this hard in a single session. Whether it holds into the close is the tell.
Regular session
$254.53
+5.01%open $242.38
A 5% intraday run to $254.53 tacks roughly $2.9 billion onto the $57.7 billion steelmaker in a single session. Moves this size are rare for a large-cap industrial, so watch whether it holds into the close.
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are trading as though the company’s messenger RNA (mRNA) cancer vaccine has already cleared its final test, even though the complete Phase 3 dataset has yet to be presented publicly. In afternoon trading, Moderna stock has…
Bitcoin Is Back at Its September High and Short Sellers Are Stacked Right Above It. What Happens If $88,000 Breaks?
Short sellers have stacked leveraged positions just above Bitcoin’s current price, and if that cluster breaks, forced buying could ignite a chain reaction with nowhere obvious to stop.
The SEC Approves the First 3x Bitcoin and Ether Funds: Understanding the Risks Involved
The SEC just greenlit triple-leveraged Bitcoin and Ether funds, but the math behind how these products work reveals a hidden trap that can drain your balance even when crypto trends in your favor.
Regular session
$24.34
+6.12%open $22.94
A 6.1% intraday run to $24.35 adds roughly $140 million to a $2.4 billion market cap in a single session. Swings this wide are routine for this lender, so size positions accordingly.
The Highest-Beta Name in Big Tech Just Ran. Here’s the Risk
Arm just posted a 187% year-to-date run on the back of real AI demand, but a beta of 3.89 turns every market hiccup into a violent swing, and the stock has already priced in a lot of good news. The question is whether the fundamentals can actually catch the valuation.